Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.
about
Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of "Anticholinergic Spectrum Disorders"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic reviewHigher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) studyAntidepressant use and cognitive deficits in older men: addressing confounding by indications with different methodsMinimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycleUse of anticholinergics and the risk of cognitive impairment in an African American populationAssociations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients.Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.Drug Burden Index in older adults: theoretical and practical issues.Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.Use of CNS medications and cognitive decline in the aged: a longitudinal population-based studyDrug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.Medication use and functional status decline in older adults: a narrative review.Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal womenImproving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy-health psychology intervention feasibility study.Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians.Long-term anticholinergic use and the aging brain.Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications.Sleep disturbances and driving practices of older drivers.Drug Burden Index and physical function in older Australian men.Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review.Systematic review of anticholinergic risk scales in older adults.Anticholinergic drug burden in older people's brain - how well is it measured?An overview of the LASER-AD study: a longitudinal epidemiological study of people with Alzheimer's disease.Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.Anticholinergics: theoretical and clinical overview.Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder.Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.A Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale.Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.
P2860
Q28070151-75153CC6-E892-4072-8C0A-E7F3FB1AC5C9Q28085414-C31E8CA1-6B46-4E1E-8F2C-E89A881EBAA6Q30559371-4CD8C4E6-9FC7-4B07-8AB7-FAFF97452597Q30661806-150E9B9D-6DF6-4565-959C-0EBA01F700E6Q33745611-CA47039B-8084-4387-A4C1-5659DCAB4CA7Q33949454-4A17177D-1203-40AC-88B4-53EDF7DA4B5AQ34002967-E47F8138-9A01-44BE-BB0B-EEE96DF6F6F0Q34016202-45B4E737-DBA3-4E71-AD00-085F6E1AAA1EQ34104256-3FB833F4-4FA6-4FB9-99C3-D7AF4311D9EAQ34198674-268B4834-7159-4E18-8342-052A86EF6D0EQ34429787-EA2A392A-8F0B-4627-AD64-9D04431902F6Q35580037-0BC9A5DF-5517-4BAE-B2E4-0E36818263BBQ35688580-9B8607C7-CD73-4098-B712-CF03896BF9EEQ36099587-17D71685-DCB0-4721-A277-374BDC8123CBQ36611322-EA623548-D21A-4E3B-A9E3-19840FD9F67EQ36732899-72834319-D305-4899-B397-009C935BA4DAQ36761616-824F76E2-F3E8-4D12-9AA0-7772B7F5C4C3Q36906645-B4EEB05B-88A5-41DB-BDA5-87B98EC12C6FQ36942845-0B7BAD12-41D2-4BF6-B6FF-35AEE302BA7FQ37230913-27E32D08-F6DE-4A0F-B96A-4AB0C2F337C3Q37321432-0A18F891-BDA6-48E4-98D4-9300DAACFB17Q37831263-22C7F8B1-922E-4303-8F8A-16DE686F84A0Q38093092-05155548-19AB-45E8-9DDF-FB998E835CBFQ38151217-50A61969-22B1-410A-8A87-6F1AC2DC1BB0Q38178372-7FACF371-A8AF-4BA6-9E29-4756C4D3CBCEQ38178373-E1DEDC8C-B3C8-4249-87FE-FF89CB9DC3E2Q38187907-654A79B6-69C1-4D4A-B365-F0CB31EC024DQ38452282-7294E321-18C0-41D8-AD91-B56BD6169BD0Q38457002-3E532546-99DC-482B-9284-71E8859A4880Q38583153-173077B7-9945-4A3C-8B3E-296E4AC02D89Q38600762-0EE2CDA2-790F-410F-809B-29C748B0A16BQ38769800-4635260F-003E-4BE7-96DE-8B44833016A7Q38802441-08E33D4D-5532-4E6E-8B09-C1331A3584C5Q38873827-5A16BA97-0486-4957-B750-8AFA07AD87EBQ38886942-A79573C8-CCDA-4DC1-866A-8295389C7E6DQ39019058-D91D04B1-CF7A-4203-99F7-F0B6DE5D2CE7Q39020998-ECF435E8-6B07-4443-A639-C5431C9C06D1Q39846163-B50B2610-DD10-4F14-A940-A1B51D308958Q41214474-ED17878D-2F7C-4D44-98E2-D406B1978D81Q41568753-CE071F82-2E22-46A7-B240-E8B740B523AC
P2860
Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cumulative anticholinergic exp ...... ecutive function in older men.
@en
Cumulative anticholinergic exp ...... ecutive function in older men.
@nl
type
label
Cumulative anticholinergic exp ...... ecutive function in older men.
@en
Cumulative anticholinergic exp ...... ecutive function in older men.
@nl
prefLabel
Cumulative anticholinergic exp ...... ecutive function in older men.
@en
Cumulative anticholinergic exp ...... ecutive function in older men.
@nl
P2860
P1476
Cumulative anticholinergic exp ...... ecutive function in older men.
@en
P2093
Joseph V Agostini
P2860
P304
P356
10.1111/J.1532-5415.2008.02009.X
P407
P577
2008-12-01T00:00:00Z